This Solicitation opportunity from Department Of Defense was posted on April 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ATROPINE SULFATE IN
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
ATROPINE SULFATE INJECTION, USP is a sterile, nonpyrogenic, preservative-free, non-DEHP pharmaceutical product supplied in 5 mL single-dose syringes with a 20-gauge by 1.5-inch protected needle and male Luer lock adapter, containing 0.1 mg per mL of atropine sulfate monohydrate for a total of 0.5 mg per syringe, with sodium chloride as an excipient. It is intended for subcutaneous, intramuscular, or intravenous administration and is labeled as RX only. The product is manufactured by PFIZER INC with NDC 00409-4910-34 and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F). Each packaging group (PG) contains ten (10) syringes, with the contract requiring a total of two packaging groups for delivery. The item has a non-extendable shelf life of 24 months, and all packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere to DLA Packaging Requirements. The product is regulated by the FDA and subject to DLA’s Master List of Technical and Quality Requirements, with all technical and quality specifications controlling over commercial standards. This procurement is issued under solicitation SPE2DP-26-T-3107 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with a firm delivery deadline of 20 days after award and delivery to Fort Bragg, North Carolina, FOB destination. The contract specifies a zero percent variance in quantity, mandatory inspection and acceptance at destination, and requires traceable shipping methods excluding parcel post. The item is not classified as hazardous under FED-STD-313 and must be commercially packaged per ASTM D3951 unless overridden by DLA requirements. The full packaging, marking, and labeling instructions are governed by DLA specifications, and all documentation must reflect government-issued identifiers in compliance with RP001 and RQ011. The need ship date is not specified, but the original required delivery date is April 28, 2026, with a response deadline for bids set for May 4, 2026, and a point of contact provided for inquiries and confirmations.
General Info
Agency
NAICS
Place of Performance
5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
ATROPINE SULFATE INJECTION,USP
RX ONLY. SUPPLIED WITH SINGLE-DOSE UNIT OF
USE SYRINGE WITH MALE LUER LOCK ADAPTER AND
PROTECTED NEEDLE. MAY BE ADMINISTERED
SUBCUTANEOUSLY, INTRAMUSCULARLY OR
INTRAVENOUSLY. STERILE AND NONPYROGENIC.
NON-DEHP, PRESERVATIVE-FREE. SIZE: 5 ML.
CONCENTRATION: 0.1 MG/ML. TOTAL
CONTENT (ATROPINE): 0.5 MG/5 ML. SYRINGE
DIMENSIONS: 20 G (GAUGE) X 1.5". EACH
MILLILITER (ML) CONTAINS ATROPINE SULFATE,
MONOHYDRATE 0.1 MG (ADULT STRENGTH) AND
SODIUM CHLORIDE, 9 MG.
.
1 PG = 10 EA
.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item. . STORE AT CONTROLLED ROOM TEMPERATURE 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE]. . RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/ . This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. .
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
PFIZER INC 86491 P/N NDC00409-4910-34
SPE2DP-26-T-3107
SECTION B
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016505163 0001 PG 2.000
NSN/MATERIAL:6505015731657
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SPE2DP-26-T-3107
SECTION B
PR: 7016505163 PRLI: 0001 CONT’D
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP61060264
RDD: 120
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:04/28/2026
SPE2DP-26-T-3107 NSN/Part Number: 6505-01-573-1657 Quantity: 2 PG Purchase Request: 7016505163QTY: 2 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS